Infectious Disease AdvisorPiperacillin-Tazobactam vs Meropenem for Resistant Bloodstream InfectionsInfectious Disease Advisor... resistance, treatment with piperacillin-tazobactam compared with meropenem did not result in a non-inferior 30-day mortality, according to data published in the Journal of the American Medical Association (ClinicalTrials.gov identifier: NCT02176122).